Moderna stock on track for 20% weekly gain after US bird flu death
Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.
Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight
Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., ...
BioSpace1h
GSK, Pfizer RSV Shots Required to Carry Guillain-Barré Syndrome Warnings
A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s ...
devdiscourse1h
Healthcare Headlines: From COVID-19 to New Pharmaceutical Ventures
Recent health news includes Donald Trump's consideration of an executive order on gas stoves, Roche's acquisition of Poseida, ...
Abzena Strengthens Board with Appointment of Biopharma Industry Leader, Dr Moncef Slaoui
Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has today announced the appointment of Dr ...
The Pharma Letter3h
FDA imposes GBS warning for RSV vaccines Abrysvo and Arexvy
The US Food and Drug Administration has imposed a label change for two new respiratory syncytial virus (RSV) vaccine rivals.
GSK, Pfizer RSV Shots Must Warn About Rare Paralysis Risk
GSK Plc and Pfizer Inc.’s vaccines for a common respiratory virus must carry warnings that they may be tied to an increased ...
MyJoyOnline4h
Exit of multinational firms due to high inflation, currency weakness – Deloitte
Deloitte said while this is expected to continue in 2025 and impact positively on consumer and investor sentiment, coupled ...
labiotech4h
Ten drugs to watch in 2025: will these therapies become blockbusters?
Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...
FDA awards GSA breakthrough status for relapsed osteosarcoma treatment
GSK has gained US Food and Drug Administration (FDA) breakthrough therapy designation (BTD) for its B7-H3-targeted ...
Benzinga.com5h
Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder
The FDA identified an estimated 9 excess GBS cases per million doses for Pfizer's Abrysvo and 7 excess cases per million for ...
Clarivate Plc: Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...